It was scheduled to run from February 2008 to December 2011 .
Medarex ran a phase II trial of ipilimumab in addition to platinum - based chemotherapy ( carboplatin ) in patients with small cell and non-small cell lung cancer .
Medarex was scheduled to run from February 2008 to December 2011 .
Medarex ran a phase II trial of ipilimumab in addition to platinum - based chemotherapy ( carboplatin ) in patients with small cell and non-small cell lung cancer .